Our Company .
Solvotrin Therapeutics is an Irish healthcare development company that enhances established therapies through innovative science with patent protection.
Headquartered in Co. Cork, Ireland, Solvotrin has a team of 19 people with the R&D team members located at Trinity College Dublin.
Founders & Investors .
Solvotrin Therapeutics was founded by CEO Pat O Flynn. Pat is a highly successful entrepreneur with over 20 years’ experience and an educational background in Engineering.
Founded in partnership with Professor Mark Ledwidge and Professor John Gilmer, Solvotrin works closely with a network of investors to drive the growth of Solvotrin Therapeutics. We blend research, data, technology, and investment to unlock opportunities and deliver strategic solutions across multiple markets.
Our Strategy .
Our Partners .
Bulgaria
Bulvax
China
Nuance Pharma
Germany
Eb Vertriebs
Greece
Bionat
Ireland
Pharmed Group
Malta
MGC Distributors
MMDS
Middle | East Africa
New Zealand
USL
Serbia
Proton
USA
The Market Performance Group
USA
Ortho Molecular